The optoelectronic sensor OPT101 have merits in advanced optoelectronic response characteristics at wavelength range for medical near-infrared spectroscopy and small-size chip design with build-in trans-impedance amplifier. Our lab is devoted to developing a series of portable near-infrared spectroscopy (NIRS) devices embedded with OPT101 for applications in intensive care unit clinics, based on NIRS principle. Here we review the characteristics and advantages of OPT101 relative to clinical NIRS instrumentation, and the most recent achievements, including early-diagnosis and therapeutic effect evaluation of thrombus, noninvasive monitoring of patients' shock severity, and fatigue evaluation. The future prospect on OPT101 improvements in noninvasive clinical applications is also discussed.
Introduction
Currently, optoelectronic sensors have been applied in fruit or stem growth monitoring in agriculture [1] , nitric oxide detection with high sensitivity [2] , pulse oximetry for pulse rate and oxygenation measurement [3] , and salivary diagnosis of stomach cancer [4] . OPT101 (Monolithic photodiode and single-supply transimpedance amplifier, Texas Instruments, America) is one type of optoelectronic sensor which converts optical signal to electronic signal without additional noise [5] and with signal amplification function. These prestigious advantages prompted OPT101 to be used in noninvasive clinics.
There are significant requirements to develop noninvasive and smart monitoring techniques in intensive care unit (ICU), such as for newborn babies and patients undergoing emergency care. For instance, shock usually causes acute blood flow reduction, anaerobic metabolism, etc., and irreversible damage and death if sustained. The inevitable hemorrhage during surgery and traumatic injury-induced shock is known as a fatal complication with a high mortality rate of~50% [6] . The conventional clinical method to estimate shock severity was to measure blood oxygen indices in the central internal jugular central vein (ScvO 2 ) [7] . However, the intermittent and invasive procedures to obtain this acceptable blood oxygen indicator actually prevented continuous shock monitoring, which is crucial for clinicians to judge the best time window to rescue the patient with shock. A noninvasive,
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Photoelectric Detector OPT101 and Applicable Probe Design
The photoelectric detector OPT101 ( Figure 1a ) is a kind of integrated photodiode with on-chip built-in transimpedance amplifier. The amplifier is designed for single or dual power-served operation, applicable to a battery-include instrument. The integration design of photodiode and a trans-impedance amplifier on a chip may effectively reduce current leakage, noise and stray capacitance-induced gain peaking. Besides, in photoconductive mode, the 8.1 × 10 −3 inch 2 photodiode offer fairly high linearity and very low dark current. Quantitatively, the working voltage of the OPT101 ranges from 2.7 V to 36 V and its quiescent current is only 120 µA. For the circuitry design of OPT101, the bandwidth at an external 5 MΩ feedback resistor and an external 10 pF capacitor is 2.5 kHz. The DC gain and the actual working voltage are 6 × 10 6 V/A and 5 V respectively. As shown in the special responsivity curve in Figure 1b and Table 1 , the responsivity of OPT101 at the specified wavelengths (735 nm, 805 nm, and 850 nm) are close to the peak value around 86%, which is higher than SiPM sensors (~5%) and APD sensors (~80%) and allows high sensitivity in sensing the light at these wavelengths.
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The photoelectric detector OPT101 ( Figure 1a ) is a kind of integrated photodiode with on-chip built-in transimpedance amplifier. The amplifier is designed for single or dual power-served operation, applicable to a battery-include instrument. The integration design of photodiode and a trans-impedance amplifier on a chip may effectively reduce current leakage, noise and stray capacitance-induced gain peaking. Besides, in photoconductive mode, the 8.1 × 10 −3 inch 2 photodiode offer fairly high linearity and very low dark current. Quantitatively, the working voltage of the OPT101 ranges from 2.7 V to 36 V and its quiescent current is only 120 μA. For the circuitry design of OPT101, the bandwidth at an external 5 MΩ feedback resistor and an external 10 pF capacitor is 2.5 kHz. The DC gain and the actual working voltage are 6 × 10 6 V/A and 5 V respectively. As shown in the special responsivity curve in Figure 1b and Table 1 , the responsivity of OPT101 at the specified wavelengths (735 nm, 805 nm, and 850 nm) are close to the peak value around 86%, which is higher than SiPM sensors (~5%) and APD sensors (~80%) and allows high sensitivity in sensing the light at these wavelengths. Table 1 shows the comparisons on the negatives and positives of OPT101 and other optoelectronic sensors used in NIRS instrumentation. Among all optoelectronic sensors listed, the sensitivity of OPT101 does not stand out; however, it is still high enough to sensitively measure hemodynamic variations in human body noninvasively. Additionally, OPT101 is of high gain and low cost. Plus, OPT101 has a built-in transimpedance amplifier and does not need any more electronics in clinical NIRS instrumentation, unlike APDs and SiPMs. It can be simply embedded with LEDs in a soft electronic circuit pad, making NIRS more portable and even wearable. The advantages of OPT101, including sensitive-enough responsivity, mini-size structure, advanced electronic properties, and low cost, make it quite suitable for our bedside care instrument design in recording light intensity variations at selected wavelengths to measure human body hemodynamics. Table 1 shows the comparisons on the negatives and positives of OPT101 and other optoelectronic sensors used in NIRS instrumentation. Among all optoelectronic sensors listed, the sensitivity of OPT101 does not stand out; however, it is still high enough to sensitively measure hemodynamic variations in human body noninvasively. Additionally, OPT101 is of high gain and low cost. Plus, OPT101 has a built-in transimpedance amplifier and does not need any more electronics in clinical NIRS instrumentation, unlike APDs and SiPMs. It can be simply embedded with LEDs in a soft electronic circuit pad, making NIRS more portable and even wearable. The advantages of OPT101, including sensitive-enough responsivity, mini-size structure, advanced electronic properties, and low cost, make it quite suitable for our bedside care instrument design in recording light intensity variations at selected wavelengths to measure human body hemodynamics. 
Good time resolution
High quantum efficiency, on-chip built-in transimpedance amplifier [28, 29, 31] Weakness Not work at very low bandwidth or low noise of the amplifier
The afterpulsing peak against autocorrelation function analysis Lower time resolution than SiPMs, lower sensitivity than APDs [28, 31] Here, OPT101 was utilized to collect light intensity signals in a certain measurement site of the human body and it converted the collected optical signals to electrical signals, such as voltage signal. The output voltage response was recorded, transferred to physiological variations, and displayed in our customized NIRS software. In our NIRS instruments with OPT101, calibration for OPT101 separately or for each sensor array configuration is not essential, which is required by absolute measurements. Based on the linear optoelectronic response and linear amplifier response, the output voltage response of OPT101 increases linearly with light intensity. The reason for this is that we actually obtain the optical density variation from the ratio of detected light intensity variation sequence to the initial detected light intensity baseline, which belongs to relative measurements. Figure 1c -f shows the probe designs with the optoelectronic detector embedded, for the applications of handhold curved scanning health detector (c), thrombosis detector (d), fatigue monitor (e), and shock status reporter (f). The quantities of detectors, the separations between the light sources and detectors, and the configurations of the light sources and detectors were different among the above applications, according to the measurement region of interest, surface geometry and data processing algorithm. For example, the handhold curved scanning health detector in Figure 1c was specially designed for measuring legs, arms, and breast with round-like geometry, thus the probe surface was designed as curved with those tissues. Separation of light sources and detectors was 2.5 cm, which was the mean of the optimized value applicable to the measured body tissue. Additionally, this detector application was of relative bilateral comparison measurement. Accordingly, the contralateral placement of the two OPT101 beside the light source was employed.
The detectors for thrombus, fatigue and shock were designed in a flexible printed circuit board with black blocking leather attached on either sites, which allowed the detectors and detecting surface to be fully and tightly attached to measure skin regions. This design effectively reduced the background noise and signal leak. The curved detector was made in a rigid circuit board design and hard encapsulated, which is easy to hold in the hand to scan on the surface of different body tissues.
During designing the detector probe as described above, the signal to noise ratio was the key concern for the optoelectronic detector application. Here, we addressed this issue by taking the human head, the most complicated tissue structure, as an example. By using the approach of Monte Carlo light propagation modeling within voxelized tissue media [35] , we computed out signal sensitivity distribution (SSD) map (Figure 2 ) within the Visible Chinese Human [36] [37] [38] to be more than 3 cm, when the signal to noise ratio was higher than the limit of the OPT101 sensor, which is 1 × 10 −7 . Moreover, the accumulated light signal from the tissue region that was deeper than 3 cm was higher than 1.27 × 10 −6 of the incident light, which also supported the sensitive and reliable sensing of light signal from the interrogated tissue volume by detector OPT101. In addition, with the usage of OPT101, fNIRS technology can be realized in a portable, compact, and compatible design.
Carlo light propagation modeling within voxelized tissue media [35] , we computed out signal sensitivity distribution (SSD) map (Figure 2 ) within the Visible Chinese Human [36] [37] [38] head model. The SSD map was shown in a pseudo color map with quantitative contours. The SSD data demonstrate that the separation scale of the light sources and detectors approved the detectable depth within tissue to be more than 3 cm, when the signal to noise ratio was higher than the limit of the OPT101 sensor, which is 1 × 10 −7 . Moreover, the accumulated light signal from the tissue region that was deeper than 3 cm was higher than 1.27 × 10 −6 of the incident light, which also supported the sensitive and reliable sensing of light signal from the interrogated tissue volume by detector OPT101. In addition, with the usage of OPT101, fNIRS technology can be realized in a portable, compact, and compatible design. 
Measurement Algorithm of NIRS
Based on the principles that the hemoglobin is the main absorber of near-infrared light while the main chromophore of human body, water, is almost transparent to near-infrared light, and that absorption spectrums of oxy-and deoxy-hemoglobin are quite different within near-infrared range, NIRS is capable of measuring hemodynamic variations with human tissue noninvasively. As shown in Figure 2 , a near-infrared source emits light into tissue, and OPT101 receives the light coming out from the tissue in the position, which is a certain distance (r0) away from the light source. With different values of r0, physiological parameters at different tissue layers are allowed to be extracted by our OPT101 involved NIRS ICU-specific devices. In detail, the detected light intensity (I) signal by OPT101 originated from the light traveling through the measured tissue is converted to optical density (OD) by the following equation:
where I0 is the initial light intensity. U0 and U are the initial converted voltage and the converted voltage signal responding to I0 and I, respectively. By using the least square fitting method, and treating the optical density as ordinate and the distance between source and sensor as abscissa, the relationship between the light diffusion factor at wavelength λi (D(λi)) and the slope (S(λi)) can be extracted as follows [9] :
Here, D(SS) is the light diffusion factor of standard sample. The absolute concentrations of HbO2 ([HbO2]) and Hb ([Hb]) are calculated by the following equations [6, 9] : 
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where I 0 is the initial light intensity. U 0 and U are the initial converted voltage and the converted voltage signal responding to I 0 and I, respectively. By using the least square fitting method, and treating the optical density as ordinate and the distance between source and sensor as abscissa, the relationship between the light diffusion factor at wavelength λ i (D(λ i )) and the slope (S(λ i )) can be extracted as follows [9] :
Here, D(SS) is the light diffusion factor of standard sample. The absolute concentrations of HbO 2 ([HbO 2 ]) and Hb ([Hb]) are calculated by the following equations [6, 9] :
where ε HbO 2 (λ i and ε Hb (λ i ) are the extinction coefficients of HbO 2 and Hb at wavelength λ i , respectively. And in our applications, we utilized 735 nm and 850 nm for HbO 2 and Hb quantification. The light attenuation factor at wavelength λ i , µ t (λ i ) is calculated by [9] : 
Here, ∆µ a (λ) is the relative change of medium absorption coefficient at wavelength λ.
ICU-Specific NIRS Device and Experiment Test
The novel applications of OPT101 as photoelectric detector for ICU-specific NIRS device development in our lab were illustrated by thrombus diagnosis and monitoring, patient shock status monitoring, and fatigue evaluation in this paper. All these applications generated devices consisted of three parts, which were the optical probe, control circuit module, and data analysis software. The light source was a 3-wavelength (735 nm, 805 nm, and 850 nm) integrated LED. All the work of data collection was approved by the ethics committee (Approval No. XHECD-2014-005).
Thrombus Diagnosis and Monitoring
Thrombus is a severe complication which may cause serious morbidity and mortality, and usually happens in patients and the postoperative population. Most patients with thrombus are at risk of developing post thrombotic dysfunctions, leading to long-term morbidity and induce ulceration, chronic swelling, skin damage, and other clinical manifestations. However, the conventional diagnosis relies on sophisticated imaging methodologies which may also induce invasive contrast agent injection and ionizing procedure [11, 12] . We proposed to develop a portable NIRS under patients' resting state for thrombus diagnosis, monitoring, and therapeutic effect evaluation [17, 22] .
The OPT101 embedded NIRS device is shown in Figure 3 . Figure 3a shows the real scene where we collected the data from a patient suffering from thrombus on clinic field monitoring. Figure 3b shows our custom device design and Figure 3c shows the placement of the light source and detector in the probe. We collected data from nine patients with thrombosis during and after therapy and from seven healthy subjects for contrast. We analyzed these data and drew the scatterplot histograms of ∆[HbO2]/∆[Hb] for statistical comparisons between both populations. Thrombolytic therapy was taken on patients every other day. We also used our device to collect ∆[HbO2] from one day before and during the treatment days to analyze the therapeutic effects between thrombus and healthy legs.
Monitoring Patients with Shock
The fatal risk of shock resulting from trauma and hemorrhage is usually high, up to 50% mortality rate according to reports [40, 41] . However, the current clinic techniques to measure shock severity of patients who suffered from intermittent and invasive procedures, which could not allow clinicians to judge the best time to rescue the patients. We developed a portable space-resolved NIRS device for bedside monitoring of patients with shock.
In this application, we recommended the tissue blood oxygen saturation (StO2) measured in the tissue surrounding the central internal jugular central vein as an indicator for shock severity. We collected data from nine patients with thrombosis during and after therapy and from seven healthy subjects for contrast. We analyzed these data and drew the scatterplot histograms of ∆[HbO 2 ]/∆[Hb] for statistical comparisons between both populations. Thrombolytic therapy was taken on patients every other day. We also used our device to collect ∆[HbO 2 ] from one day before and during the treatment days to analyze the therapeutic effects between thrombus and healthy legs.
In this application, we recommended the tissue blood oxygen saturation (StO 2 ) measured in the tissue surrounding the central internal jugular central vein as an indicator for shock severity. 
Compared to thrombus diagnosis, the NIRS monitor for patients with shock ( Figure 4a ) offered the measurement of physiological parameters in the lateral neck region (Figure 4c) . The design of a flexible optical probe was space-resolved (Figure 4b) , allowing absolute measurement of [HbO 2 ] and [Hb] . Figure 4a shows the device for shock monitoring. We collected data from nine patients with thrombosis during and after therapy and from seven healthy subjects for contrast. We analyzed these data and drew the scatterplot histograms of ∆[HbO2]/∆[Hb] for statistical comparisons between both populations. Thrombolytic therapy was taken on patients every other day. We also used our device to collect ∆[HbO2] from one day before and during the treatment days to analyze the therapeutic effects between thrombus and healthy legs.
In this application, we recommended the tissue blood oxygen saturation (StO2) measured in the tissue surrounding the central internal jugular central vein as an indicator for shock severity. There were one near-infrared light source and two detectors on the probe of the monitor for patients with shock. The distances between the light source and the two OPT101 detectors were slightly different, r 1 and r 2 respectively. The angle from one detector to the other regarding the source point as the center was α. The value of α varied at the range of 0 • to 13.5 • . Moreover, the typical value of the angle was between 4.5 • and 9.5 • . The set of the angle was due to the two restrictions, which were the safe distance between OPT101 and slight difference between r 1 and r 2 . With the differential set of r 1 and r 2 , as well as the absolute measure algorithm, we were able to obtain the measurement of StO 2 in the shock-status-sensitive region, the tissue surrounding the central internal jugular central vein. We acquired data from 12 patients one day after shock treatment. For comparison, we analyzed not only StO 2 , but also ScvO 2 which was a golden standard indicator for shock prediction, by linear analysis and Bland-Altman plot [6] .
Fatigue Evaluation
The doctors and nurses usually work long hours in the ICUs, accordingly fatigue becomes a severe problem requiring quantitative management and proper intervention. Here we focused on the fatigue induced by prolonged work or operation. A computer game playing paradigm was used to induce the ICU clinicians' working fatigue. We recruited 10 healthy subjects to play computer games for 7 h with a realistic driving simulator platform as shown in Figure 5a . Subjects were instructed to take visual selective attention test every hour during the whole 7-h computer game. We collected brain activities data with a portable NIRS imager (probe shown in Figure 5b ) attached on the subjects' foreheads at the beginning of driving and then every 1 h (Figure 5a There were one near-infrared light source and two detectors on the probe of the monitor for patients with shock. The distances between the light source and the two OPT101 detectors were slightly different, r1 and r2 respectively. The angle from one detector to the other regarding the source point as the center was α. The value of α varied at the range of 0° to 13.5°. Moreover, the typical value of the angle was between 4.5° and 9.5°. The set of the angle was due to the two restrictions, which were the safe distance between OPT101 and slight difference between r1 and r2. With the differential set of r1 and r2, as well as the absolute measure algorithm, we were able to obtain the measurement of StO2 in the shock-status-sensitive region, the tissue surrounding the central internal jugular central vein. We acquired data from 12 patients one day after shock treatment. For comparison, we analyzed not only StO2, but also ScvO2 which was a golden standard indicator for shock prediction, by linear analysis and Bland-Altman plot [6] .
The doctors and nurses usually work long hours in the ICUs, accordingly fatigue becomes a severe problem requiring quantitative management and proper intervention. Here we focused on the fatigue induced by prolonged work or operation. A computer game playing paradigm was used to induce the ICU clinicians' working fatigue. We recruited 10 healthy subjects to play computer games for 7 h with a realistic driving simulator platform as shown in Figure 5a . Subjects were instructed to take visual selective attention test every hour during the whole 7-h computer game. We collected brain activities data with a portable NIRS imager (probe shown in Figure 5b ) attached on the subjects' foreheads at the beginning of driving and then every 1 h (Figure 5a During NIRS data recording, we also recorded the response of subjects to the attention stimuli on keyboard and reaction time. For data analysis, we composited the mean behavioral factor from 10 subjects at every attention test as accuracy/RT to quantify the mental fatigue of subjects. Then we analyzed the relationship between the hemodynamic parameters and the behavioral data accuracy/RT following with the fatigue increment induced by computer game playing. We also computed the prefrontal activation map with fatigue degree increase for intuitively visualizing fatigue adjustment on prefrontal activity. During NIRS data recording, we also recorded the response of subjects to the attention stimuli on keyboard and reaction time. For data analysis, we composited the mean behavioral factor from 10 subjects at every attention test as accuracy/RT to quantify the mental fatigue of subjects. Then we analyzed the relationship between the hemodynamic parameters and the behavioral data accuracy/RT following with the fatigue increment induced by computer game playing. We also computed the prefrontal activation map with fatigue degree increase for intuitively visualizing fatigue adjustment on prefrontal activity. between the normal subjects and thrombus patients. In general, the value of ∆[HbO 2 ]/∆[Hb] of the normal subjects (11.0 ± 0.95) are higher than those of the thrombus patients (9.6 ± 1.10). Student t-test also shows that the above measurements are dramatically different between normal subjects and thrombus patients (p < 0.001). On the other side, Figure 6b shows the hemodynamic response to therapeutic effect. The value of ∆[HbO 2 ] in thrombus legs decreases after therapy, and increases gradually during the recovery phase and finally reaches a significantly higher value after two days post treatment. For a healthy leg, the value of ∆[HbO 2 ] recovers to the initial state in one day and then remains stable after the therapy. Accordingly, the hemodynamic response monitored by our noninvasive NIRS thrombus monitor is shown to be capable of differentiating thrombus region from health region of human body and evaluating the therapeutic effect, either from the composed hemodynamic parameter (∆[ Figure 6a shows a comparison of the composed hemodynamic parameter ∆[HbO2]/∆[Hb] between the normal subjects and thrombus patients. In general, the value of ∆[HbO2]/∆[Hb] of the normal subjects (11.0 ± 0.95) are higher than those of the thrombus patients (9.6 ± 1.10). Student t-test also shows that the above measurements are dramatically different between normal subjects and thrombus patients (p < 0.001). On the other side, Figure 6b shows the hemodynamic response to therapeutic effect. The value of ∆[HbO2] in thrombus legs decreases after therapy, and increases gradually during the recovery phase and finally reaches a significantly higher value after two days post treatment. For a healthy leg, the value of ∆[HbO2] recovers to the initial state in one day and then remains stable after the therapy. Accordingly, the hemodynamic response monitored by our noninvasive NIRS thrombus monitor is shown to be capable of differentiating thrombus region from health region of human body and evaluating the therapeutic effect, either from the composed hemodynamic parameter ( 
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Monitoring Patients with Shock
As a gold standard indicator for prediction of shock severity, ScvO2 data was also collected by the conventional blood drop sampling and blood-gas analysis for each subject during the experiment. ScvO2 was employed as a contrast to test whether StO2 measured by NIRS shock monitor was reliable and sensitive to monitor shock severity. Figure 7a shows a significant linear regression between StO2 and ScvO2. The correlation coefficient between the results of StO2 and ScvO2 is high (R = 0.843, p < 0.001). As shown in Figure 7b , there are only three data points out of the total 12 data which fall over the 95% confidence interval for StO2. However, those three data points are quite close to the 95% confidence interval. Figure 7c is the Bland-Altman plot for StO2 and ScvO2, which clearly illustrates that there exists a fairly good agreement between these two parameters (the mean difference is 4.16%). It indicates that StO2 measured in the ScvO2 origin site of the human body by NIRS has the potential to substitute the current golden standard parameter ScvO2. 
As a gold standard indicator for prediction of shock severity, ScvO 2 data was also collected by the conventional blood drop sampling and blood-gas analysis for each subject during the experiment. ScvO 2 was employed as a contrast to test whether StO 2 measured by NIRS shock monitor was reliable and sensitive to monitor shock severity. Figure 7a shows a significant linear regression between StO 2 and ScvO 2 . The correlation coefficient between the results of StO 2 and ScvO 2 is high (R = 0.843, p < 0.001). As shown in Figure 7b , there are only three data points out of the total 12 data which fall over the 95% confidence interval for StO 2 . However, those three data points are quite close to the 95% confidence interval. Figure 7c is the Bland-Altman plot for StO 2 and ScvO 2 , which clearly illustrates that there exists a fairly good agreement between these two parameters (the mean difference is 4.16%). It indicates that StO 2 measured in the ScvO 2 origin site of the human body by NIRS has the potential to substitute the current golden standard parameter ScvO 2 . 
Fatigue Evaluation and Data
As for fatigue evaluation, Figure 8 shows that both the prefrontal activity induced ∆[HbO2] measured by NIRS imager and the behavioral performance factor accuracy/RT varied nonlinearly along with the time duration of playing the computer game. Figure 8a displays the prefrontal activation map followed by the continuous computer game duration. The pseudo color map shows that the amplitude of the activation increases gradually in the prefrontal lobe, especially in the middle bottom prefrontal region, which is highlighted in a black rectangular box in the map (Figure 8a ). After we extracted the mean value of brain activation in terms of ∆[HbO2] of every subject, we plot its variation with duration time statistically, as well as the behavioral performance. We find that the fatigue-induced ∆[HbO2] rise up while fatigue-induced behavioral performance fall down in a similar opposite tendency (Figure 8b) . Interestingly, the statistical mean ∆[HbO2] and accuracy/RT shows a strong negative linear correlation (R = −0.896, p = 0.002). 
As for fatigue evaluation, Figure 8 shows that both the prefrontal activity induced ∆[HbO 2 ] measured by NIRS imager and the behavioral performance factor accuracy/RT varied nonlinearly along with the time duration of playing the computer game. Figure 8a displays the prefrontal activation map followed by the continuous computer game duration. The pseudo color map shows that the amplitude of the activation increases gradually in the prefrontal lobe, especially in the middle bottom prefrontal region, which is highlighted in a black rectangular box in the map (Figure 8a ). After we extracted the mean value of brain activation in terms of ∆[HbO 2 ] of every subject, we plot its variation with duration time statistically, as well as the behavioral performance. We find that the fatigue-induced ∆[HbO 2 ] rise up while fatigue-induced behavioral performance fall down in a similar opposite tendency (Figure 8b 
Conclusions and Discussion
With the optoelectronic detector OPT101, we innovatively developed a series of NIRS devices for ICU, including the common health scanner, the thrombus monitor, monitor for patients with shock, and the imager for fatigue evaluation. All of these devices were noninvasive, portable, compact, and real-time. These devices surpassed the current methods or conventional techniques used in those severe diseases in integrated advantages of noninvasive, nonionizing, and continuous measurements. The experimental studies of each device displayed good reliability and sensitivity. The whole study fully demonstrated the medical and life science application of OPT101 in near-infrared spectroscopy, and indicated the great potential of OPT101, as well as the feasibility of OPT101 embedded portable NIRS in ICU and multifunctional home health care.
Our study on thrombus monitor showed that NIRS monitoring of ∆[HbO 2 ]/∆[Hb] played a fairly sensitive role in diagnosis of thrombus, as well as the therapeutic effect tracking and evaluation. Of note, the monitor probe was applicable to the early thrombosis tissues, such as legs, which indicated the home care use of this device in early detection and development of thrombosis. In the application of monitoring patients with shock, we found that the StO 2 measured in the tissue surrounding the central jugular vein is quite consistent with the golden standard indicator ScvO 2 , which was measured by blood drop sampling and blood-gas analysis. Apparently, the ScvO 2 could not be measured continuously and in real time, which means that it was actually not possible to monitor shock and to predict the time window for rescuing the patients. In contrast, StO 2 measured by NIRS shock monitoring was quite appropriate for monitoring the onset of the shock and severity change of the shock. For fatigue evaluation, the variation ∆[HbO 2 ] measured by the NIRS fatigue imager increased with the working time and were highly negatively correlated with fatigue-adjusted behavioral performance score (R = −0.899, p = 0.0026). This finding strongly supported the quantitative evaluation of fatigue in a noninvasive and in-situation way by NIRS.
In the future, we would like to expand the range of OPT101 embedded NIRS for more applications in life science. The sensitivity of OPT101 is expected to be closer and closer to the expensive sensors in other kinds of NIRS instruments, which may make the NIRSs compact, low-cost, and close-to-translational as well. In addition, according to Table 1 , the SiPM sensor has been developed to be smaller and smaller and with good characteristics, especially high time resolution, which suggests great potential in compact time-resolved or correlational NIRS.
Additionally, even OPT101 is small enough at the current stage, it is also expected to be in patch type design in the near future, which would allow the flexible and wearable design of the above NIRS devices for smarter healthcare.
